Works matching IS 00071188 AND DT 2018 AND VI 175 AND IP 2
Results: 18
Protease-activated receptor 1 inhibition protects mice against thrombin-dependent respiratory syncytial virus and human metapneumovirus infections.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Inventing new therapies without reinventing the wheel: the power of drug repurposing.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice.
- Published in:
- 2018
- By:
- Publication type:
- journal article
5-HT<sub>1F</sub> receptor-mediated mitochondrial biogenesis for the treatment of Parkinson's disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Issue Information.
- Published in:
- British Journal of Pharmacology, 2018, v. 175, n. 2, p. 163, doi. 10.1111/bph.13995
- Publication type:
- Article
Olaparib protects cardiomyocytes against oxidative stress and improves graft contractility during the early phase after heart transplantation in rats.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Drug repurposing screens and synergistic drug-combinations for infectious diseases.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ibuprofen and diclofenac treatments reduce proliferation of pancreatic acinar cells upon inflammatory injury and mitogenic stimulation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Glycogen phosphorylase inhibition improves beta cell function.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Drug repurposing from the perspective of pharmaceutical companies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dexpramipexole improves bioenergetics and outcome in experimental stroke.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia/reperfusion injury and for treating heart failure.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The clinically used PARP inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third‐degree burn injury.
- Published in:
- British Journal of Pharmacology, 2018, v. 175, n. 2, p. 232, doi. 10.1111/bph.13735
- By:
- Publication type:
- Article
β-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Development of a stretch-induced neurotrauma model for medium-throughput screening in vitro: identification of rifampicin as a neuroprotectant.
- Published in:
- 2018
- By:
- Publication type:
- journal article